How Supplied:
4% cream, 56.8 g
Indications and Usage:
Lustra and Lustra-AF are indicated for the gradual treatment of ultraviolet induced dyschromia and discoloration resulting from the use of oral contraceptives, pregnancy, hormone replacement therapy, or skin trauma.
Prescribing Instructions:
Prescribing Information Instructions [PDF]
Side Effects and Contraindications:
Side effects may include occasional cutaneous hypersensitivity (localized contact dermatitis) may occur, in which case the medication should be discontinued and the physician notified immediately. Lustra and Lustra-AF are contraindicated in any patient that has a prior history of hypersensitivity or allergic reaction to hydroquinone or any of the other ingredients. The safety of topical hydroqinone use during pregnancy or on children (12 years and under) has not been established.
Company:
Taro Pharmaceuticals
866-923-4914
www.taropharma.com
MyList
Drugs
